NCT02090608View on ClinicalTrials.gov

Paricalcitol in Fabry Disease

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Fabry DiseaseProteinuria
Interventions
DRUG

Paricalcitol

Paricalcitol was administered at the dose of 1 mcg/die

Trial Locations (1)

80129

federico II university, department of nephrology, Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT02090608 - Paricalcitol in Fabry Disease | Biotech Hunter | Biotech Hunter